<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1237076/" ref="ordinalpos=1993&amp;ncbi_uid=654519&amp;link_uid=PMC1237076" image-link="/pmc/articles/PMC1237076/figure/fig7/" class="imagepopup">Figure 7. From: The Wnt-NLK <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">Pathway</span> Inhibits A-Myb Activity by Inhibiting the Association with Coactivator CBP and Methylating Histone H3. </a></div><br /><div class="p4l_captionBody">The Wnt-NLK pathway inhibits the activity of Myb family of proteins by two different mechanisms. The Wnt-NLK pathway inhibits A-Myb activity by blocking the interaction between A-Myb and CBP and inducing the methylation of histone H3-K9. In contrast, the Wnt-NLK pathway inhibits c-Myb activity by inducing proteasome-dependent c-Myb degradation.</div></div>